We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Proteasome Blocker Brings Glaucoma Gene Therapy Closer

News   Jan 17, 2018 | Original Story from the University of Wisconsin-Madison

 
Proteasome Blocker Brings Glaucoma Gene Therapy Closer

To improve gene transfer to treat the blinding disease glaucoma, the front of an untreated eye (left) is compared to an eye (right) pre-treated with a gene delivery enhancer. The green marker reveals the expression of the gene introduced through gene therapy, showing improved delivery using the enhancer. Credit: Curtis Brandt/Paul Kaufman, University of Wisconsin-Madison

 
 
 

RELATED ARTICLES

Whole Genome Sequencing for Personalized Antibiotic Therapy

News

Researchers have added to evidence that rapid resistance gene sequencing technology can accurately speed the identification of specific antibiotic-resistant bacteria strains that sicken and kill some patients.

READ MORE

New Biomarkers Detect 70% of Pancreatic Cancer, a Vast Improvement

News

A new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before it reaches more advanced and difficult-to treat stages.

READ MORE

World’s First Genetically Enhanced Human Vascular Cells

News

Scientists have generated the world's first genetically enhanced human vascular cells by targeting a single longevity gene, FOXO3.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE